Weekend news – Peru suspends Sinopharm COVID-19 vaccine trial after ‘adverse event’

This is from the weekend, posting as an ICYMI on China vaccine developer Sinopharm Group.

  • is conducting trials in Peru
  • with around 12,000 volunteers
But trials have been suspended due to a “serious adverse event” that occurred with one of the volunteers. The event is “under investigation to determine if it is related to the vaccine or if there is another explanation”.
Go to top